Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

NLTX Neoleukin Therapeutics Inc

3,49

0,00 (0,00%)

17 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form S-4/A - Registration of securities, business combinations: [Amend]

0001193125-23-258478.txt

Neoleukin Therapeutics (NASDAQ:NLTX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Neoleukin Therapeutics Charts.

Neoleukin Therapeutics (NASDAQ:NLTX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Neoleukin Therapeutics Charts.

News Neoleukin Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 9 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 9 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 7 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 21 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 18 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 17 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 17 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 17 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 17 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 17 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 3 Juni 2024 (8 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 10 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Weitere Neoleukin Therapeutics Inc News-Artikel

BlackRock Institutional ...

BNP Paribas Issuance

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen